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Abstract
© 2018 A. P. Burlaka et al. Excess body weight has been causally linked to an increased risk of
different cancer types, including colorectal cancer (CRC) but the mechanisms underlying this
association are practically unknown. We investigate redox state-superoxide (SO) generation
rate, activity of complex I in electron transport chain (ETC) of mitochondria and of dinitrosyl iron
complexes  by  electron  paramagnetic  resonance;  activity  of  matrix  metalloproteinase
(gelatinase) MMP-2 and MMP-9 by gel zymography of adipose tissues (AT) from 46 patients (64.0
± 1.6 y.o.) with CRC (II-III stages, pT2-3N0-2M0) in the AT adjacent to tumor (ATAT) and at a
distance of 3 cm from the tumor (ATD) to follow the connection of the AT redox state with some
of the tumor microenvironment indicators. We have incubated the AT species with the tumor
necrosis factor α (TNF-α) to follow its influence on the measured values. As a control, normal AT
(NAT) obtained during the liposuction is used. Tumor-induced changes in mitochondrial ETC of
ATAT, particularly for Complex I, lead to the enhanced SO generation and consequent oxidative
modifications of DNA in ATAT (up to 6.1 times higher than that in NAT and 3.7 times higher than
that  in  ATD,  p  < 0.05).  Gelatinase activity  in  ATAT is  significantly  higher  than in  ATD.  A
considerable effect of TNF-α on ATAT and ATD (but not on NAT, i.e., only on the tissues where
the  reprogramming  of  metabolism  has  already  occurred  under  the  influence  of  tumor)
manifested  in  increase  of  cellular  hypoxia,  gelatinase  activity,  and  SO  generation  rate  is
observed. The results can be used for better understanding the mechanism(s) of metabolic
symbiosis of tumor and AT as well as serving as a basis for new therapeutic approaches.
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